{"database": "openregs", "table": "documents", "rows": [["FDA-2022-D-0588-0012", "FDA", "FDA-2022-D-0588", "Compliance Policy Regarding Blood and Blood Component Donation Suitability, Donor Eligibility and Source Plasma Quarantine Hold Requirements; Guidance for Industry; Availability.", "Rule", "Final Rule", "2023-10-18T04:00:00Z", 2023, 10, "2023-10-18T04:00:00Z", null, "2023-10-19T13:45:19Z", "2023-22957", 0, 0, "090000648610438b"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2022-D-0588-0012"], "units": {}, "query_ms": 4.125115985516459, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}